Researchers elucidate transport pathway of immune system substances

October 18, 2012, Helmholtz Association of German Research Centres

To transport substances from the site of their production to their destination, the body needs a sophisticated transport and sorting system. Various receptors in and on the cells recognize certain molecules, pack them and ensure that they are transported to the right place. One of these receptors is Sortilin. It is present in the cells of the nervous system, the liver, and the immune system. Studies by Stefanie Herda and Dr. Armin Rehm (Max Delbrück Center for Molecular Medicine, MDC, Berlin-Buch and Charité–Universitätsmedizin Berlin) and the immunologist Dr. Uta Höpken (MDC) have now shown that the receptor Sortilin plays an important role in the function of the immune system.

In the search for diseases, the T cells of the immune system go on patrol throughout the body. If they encounter a cell infected by viruses, they bind to it and secrete substances that ensure that the dies. One of these substances is granzyme A, which penetrates the infected cell and induces programmed cell death. In addition, the immune cells secrete , which induces the surrounding cells to have a stronger immune response.

Interferon-gamma is produced by (formerly: T killer cells), T and . It enhances the activity of immune cells and induces other cells of the body to increasingly present fragments of the pathogen on their surface so that the T cells can find the affected cells more easily. To facilitate the transport of interferon-gamma from the interior of the T cell where it is produced to the where it can be released, the cell uses its interior processing and transport system, to which the belongs.

If one were to imagine the Golgi apparatus as a post office, Sortilin's task is to wrap the interferon-gamma cargo into these packages and navigate them to their destination. Without Sortilin, however, the packages cannot be delivered and remain in the post office, that is in the Golgi apparatus. Correspondingly, in the serum, i.e. outside of the cell, too little interferon-gamma is present. Thus, lack of interferon-gamma is not caused by diminished production, but rather by reduced or abrogated transport activity, eventually preventing the interferon-gamma from reaching its destination. This in turn leads to a weakened immune defense system since the interferon can only exert its immune-stimulating effect when it is released from the .

While the transport of interferon-gamma is disturbed in the absence of Sortilin, the transport of granzyme A, which destroys diseased cells directly, is more effective. Granzyme A uses another transport pathway, which is dependent on a multi-part receptor complex. This complex includes the molecule VAMP7. Together with its binding partners, this molecule ensures that transport packages containing granzyme A as part of its cargo reach their correct address in the cell. The work of the researchers led by Dr. Rehm suggests that Sortilin has an indirect influence on VAMP7 by promoting transport routes that lead to the degradation of VAMP7. In cells lacking Sortilin the researchers were able to detect increased VAMP7. This condition allowed for a more efficient transport and therefore an increased release of granzyme A.

Accordingly, Sortilin influences two different transport pathways for key immunological effector molecules in an opposite manner. Without Sortilin, less interferon-gamma is available, instead there is an increased level of granzyme A. But the increased concentration of granzyme A cannot compensate for the interferon gamma deficiency. In the experiment, the immune system of mice in which the researchers had deactivated Sortilin was significantly weaker and the fight against viruses and bacteria was less effective. The advantage for these animals, however, was that autoimmune diseases – that is, diseases in which one's own immune system reacts against the body – were much less pronounced.

More information: The sorting receptor Sortilin exhibits a dual function in exocytic trafficking of interferon-γ and granzyme A in T cells, Immunity, doi: 10.1016/j.immuni.2012.07.012

Related Stories

Recommended for you

Novel genomic tools provide new insight into human immune system

January 19, 2018
When the body is under attack from pathogens, the immune system marshals a diverse collection of immune cells to work together in a tightly orchestrated process and defend the host against the intruders. For many decades, ...

Genomics reveals key macrophages' involvement in systemic sclerosis

January 18, 2018
A new international study has made an important discovery about the key role of macrophages, a type of immune cell, in systemic sclerosis (SSc), a chronic autoimmune disease which currently has no cure.

First vaccine developed against grass pollen allergy

January 18, 2018
Around 400 million people worldwide suffer in some form or other from a grass pollen allergy (rhinitis), with the usual symptoms of runny nose, cough and severe breathing problems. In collaboration with the Viennese firm ...

Researchers discover key driver of atopic dermatitis

January 17, 2018
Severe eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that is driven by an allergic reaction. In their latest study, researchers at La Jolla Institute reveal an important player that promotes ...

Who might benefit from immunotherapy? New study suggests possible marker

January 16, 2018
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments.

Researchers identify new way to unmask melanoma cells to the immune system

January 16, 2018
system, which enables these deadly skin cancers to grow and spread.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.